RESUMO
Congenital adrenal hyperplasia is the most frequent cause of adrenal insufficiency and ambiguous genitalia in newborn children. In contrast to congenital adrenal hyperplasia due to 21-hydroxylase and 11 beta-hydroxylase deficiencies, which impair steroid formation in the adrenal cortex, exclusively, classical 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) deficiency affects steroid biosynthesis in the gonads as well as in the adrenals. The structures of the highly homologous type I and II 3 beta-HSD genes have been analyzed in three male pseudohermaphrodite 3 beta-HSD deficient patients from unrelated families in order to elucidate the molecular basis of classical 3 beta-HSD deficiency from patients exhibiting various degrees of severity of salt losing. The nucleotide sequence of DNA fragments generated by selective polymerase chain reaction amplification that span the four exons, the exon-intron boundaries, as well as the 5'-flanking region of each of the two 3 beta-HSD genes have been determined in the three male patients. The five point mutations characterized were all detected in the type II 3 beta-HSD gene, which is the gene predominantly expressed in the adrenals and gonads, while no mutation was detected in the type I 3 beta-HSD gene, predominantly expressed in the placenta and peripheral tissues. The two male patients suffering from severe salt-losing 3 beta-HSD deficiency are compound heterozygotes, one bearing the frame-shift mutation 186/insC/187 and the missense mutation Y253N, while the other bears the nonsense mutation W171X and the missense mutation E142K. The influence of the detected missense mutations on enzymatic activity was assessed by in vitro expression analysis of mutant recombinant enzymes generated by site-directed mutagenesis in heterologous mammalian cells. Recombinant mutant type II 3 beta-HSD enzymes carrying Y253N or E142K substitutions exhibit no detectable activity. On the other hand, the nonsalt-losing patient is homozygous for the missense mutation A245P. This mutation decreases 3 beta-HSD activity by approximately 90%. The present findings, describing the first missense mutations in the human type II 3 beta-HSD gene, provide unique information on the structure-activity relationships of the 3 beta-HSD superfamily. Moreover, the present findings provide a molecular explanation for the enzymatic heterogeneity responsible for the severe salt-losing form to the clinically inapparent salt-wasting form of classical 3 beta-HSD deficiency.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
3-Hidroxiesteroide Desidrogenases/deficiência , 3-Hidroxiesteroide Desidrogenases/genética , Hiperplasia Suprarrenal Congênita/genética , 3-Hidroxiesteroide Desidrogenases/química , Sequência de Aminoácidos , Animais , Sequência de Bases , Linhagem Celular , DNA/química , Mutação da Fase de Leitura , Humanos , Immunoblotting , Masculino , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Mutação , Linhagem , Mutação Puntual , Reação em Cadeia da Polimerase , Pregnenolona/metabolismo , Progesterona/metabolismoRESUMO
We describe a patient who suffered from ophthalmic trigeminal neuralgia as an isolated symptom of a noninvasive pituitary tumor. Bromocriptine appeared to provoke the attacks within hours. This provocation could be prevented by domperidone. After adenomectomy, both spontaneous and induced attacks disappeared. Acute transient cell swelling may be the mechanism by which bromocriptine induced the neuralgic attacks.
Assuntos
Bromocriptina/efeitos adversos , Neoplasias Hipofisárias/complicações , Neuralgia do Trigêmeo/etiologia , Adenoma/sangue , Adenoma/complicações , Adenoma/tratamento farmacológico , Bromocriptina/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Hipofisárias/sangue , Neoplasias Hipofisárias/tratamento farmacológico , Prolactina/sangue , Neuralgia do Trigêmeo/sangue , Neuralgia do Trigêmeo/induzido quimicamenteRESUMO
The presence of P-glycoprotein, associated with multiple drug resistance and present in the normal adrenal cortex, was studied in 15 cases of adrenocortical carcinoma. P-glycoprotein was found in eight tumours; no correlation was found with clinical presentation, steroid production or histological index. 10 patients received mitotane. Remarkably, 3 patients with P-glycoprotein-positive tumours achieved complete remission. On the other hand, 2 patients with P-glycoprotein-negative tumours showed progression of the disease despite mitotane treatment. These findings suggest that the expression of P-glycoprotein in adrenocortical carcinoma is not related to clinical manifestations, steroid production, histological index or response to mitotane therapy.
Assuntos
Neoplasias do Córtex Suprarrenal/metabolismo , Proteínas de Transporte/metabolismo , Glicoproteínas de Membrana/metabolismo , Proteínas de Neoplasias/metabolismo , Membro 1 da Subfamília B de Cassetes de Ligação de ATP , Neoplasias do Córtex Suprarrenal/tratamento farmacológico , Neoplasias do Córtex Suprarrenal/patologia , Feminino , Humanos , Masculino , Mitotano/uso terapêutico , PrognósticoRESUMO
After finding prolonged bleeding times in 2 patients treated with mitotane, we prospectively studied 7 patients with adrenocortical cancer on mitotane therapy. Before and 1 and 2 or more weeks after starting mitotane we determined the platelet counts, bleeding times and global coagulation parameters. All patients had a normal bleeding time before treatment. In 6 cases the bleeding time became prolonged (245-555 s). 4 patients exhibited platelet aggregation responses compatible with an aspirin-like defect. It is concluded that mitotane may cause a clinically relevant defect of platelet function.
Assuntos
Neoplasias do Córtex Suprarrenal/tratamento farmacológico , Tempo de Sangramento , Carcinoma/tratamento farmacológico , Mitotano/efeitos adversos , Adolescente , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mitotano/uso terapêutico , Agregação Plaquetária/efeitos dos fármacos , Inibidores da Agregação Plaquetária/uso terapêutico , Contagem de Plaquetas/efeitos dos fármacos , Fator de von Willebrand/químicaRESUMO
The distribution of o,p'-DDD in various body compartments of patients being treated for metastatic adrenocortical carcinoma was studied. A highly significant semilogarithmic relationship was found between plasma and adipose tissue concentrations during therapy and between plasma and brain at autopsy. A linear relationship was found at autopsy between concentrations in adipose tissue and those in various other tissues, such as tumour and brain. The semilogarithmic relationship can be explained by the assumption of two plasma pools for o,p'-DDD, one with low affinity and high capacity and one with high affinity and low capacity. Plasma concentrations must be carefully monitored to obtain an impression of the tumour concentration and to detect impending central nervous system intoxication.
Assuntos
Mitotano/metabolismo , Tecido Adiposo/metabolismo , Autopsia , Humanos , Mitotano/sangue , Mitotano/uso terapêutico , Distribuição TecidualRESUMO
Plasma levels of o,p'-DDD were measured after ingestion of a single oral dose. At the onset of therapy o,p'-DDD was administered as commercially available tablets and granules and in milk, chocolate, and an oil emulsion to 9, 12, 14, 10, and 6 patients, respectively. Following administration in chocolate, emulsion, and milk significantly higher mean plasma levels were recorded in the first 5- and 10-h periods than after tablets. Granules gave significantly lower plasma levels than all other forms. Plasma levels were also measured during maintenance therapy, when a total of 200 g o,p'-DDD was administered to 22 patients with adrenocortical carcinoma. The plasma disappearance rate after termination of long-term therapy was found to be between 18 and 159 days. The recovery of o,p'-DDD from faeces was about five times higher after ingestion of tablets than after administration in oil emulsion and milk. As far as the rapid increase in plasma levels and patient compliance are concerned, the best results were obtained with the milk powder mixture.
Assuntos
Neoplasias do Córtex Suprarrenal/sangue , Antineoplásicos/sangue , Mitotano/sangue , Administração Oral , Neoplasias do Córtex Suprarrenal/tratamento farmacológico , Antineoplásicos/administração & dosagem , Síndrome de Cushing/sangue , Síndrome de Cushing/tratamento farmacológico , Emulsões , Fezes/análise , Humanos , Mitotano/administração & dosagem , ComprimidosRESUMO
We found that the distribution of the lipophilic chemotherapeutic agent o,p'-DDD (mitotane) among serum (lipo)proteins was altered in hypertriglyceridemia, with relatively more o,p'-DDD accumulating in the chylomicron and very-low-density lipoprotein (VLDL) fraction. Intralipid, an artificial chylomicron emulsion, or isolated VLDL could extract o,p'-DDD from the other serum (lipo)proteins. There was an inverse relationship between the relative amount of o,p'-DDD found in the fraction exhibiting a density of less than 1.006 g/ml (chylomicrons plus VLDL) and the relative amount observed in the LDL or HDL fractions of serum. Our results indicate that hypertriglyceridemia may impede the entry of o,p'-DDD into the brain or the adrenals. For therapeutic monitoring of o,p'-DDD levels in severe hypertriglyceridemia, we recommend that the chylomicron and VLDL fraction first be removed from the serum by ultracentrifugation.
Assuntos
Hipertrigliceridemia/sangue , Lipoproteínas/sangue , Mitotano/sangue , Neoplasias do Córtex Suprarrenal/sangue , Neoplasias do Córtex Suprarrenal/tratamento farmacológico , Carcinoma/sangue , Carcinoma/tratamento farmacológico , Cromatografia Gasosa , Quilomícrons/sangue , Humanos , Lipoproteínas/isolamento & purificação , Mitotano/uso terapêutico , Valores de Referência , Fatores de TempoRESUMO
A large family with adrenoleukodystrophy is described and the case histories of two clinically symptomatic and related male patients are presented. Clinical, biochemical and genetic screening of their family demonstrated two clinically affected males, one biochemically affected male and five carrier females. Two women were symptomatic; one suffered an acute exacerbation. One female was diagnosed as a carrier, based on genetic analysis and the family history only. Endocrinological screening was performed in the five affected males, demonstrating an elevated adrenocorticotrophic hormone level and a normal cortisol level in two, as evidence of compensated adrenocortical failure.
Assuntos
Adrenoleucodistrofia/genética , Hormônio Adrenocorticotrópico/sangue , Adrenoleucodistrofia/sangue , Adrenoleucodistrofia/diagnóstico , Idoso , DNA/análise , Erros de Diagnóstico , Ácidos Graxos/sangue , Feminino , Triagem de Portadores Genéticos , Humanos , Hidrocortisona/sangue , Masculino , Pessoa de Meia-Idade , Esclerose Múltipla/diagnóstico , Linhagem , Fenótipo , Globulina de Ligação a Hormônio Sexual/análiseRESUMO
A urinary steroid profile from a patient with suspected 3 beta-HSD deficiency was prepared using capillary gas chromatography, employing only enzymatic deconjugation with Helix pomatia juice. In the chromatogram only very small peaks of dehydroepiandrosterone and 5-pregnenetriol were visible apart from other, for the diagnosis non-significant, peaks. However, after repeating the analysis including an additional solvolysis step, highly significant peaks of DHEA and 5-pregnenetriol became apparent, which suggests the necessity for a solvolysis step for a positive proof of 3 beta-HSD deficiency by urinary steroid profiling.
Assuntos
3-Hidroxiesteroide Desidrogenases/deficiência , Esteroides/urina , Hiperplasia Suprarrenal Congênita/enzimologia , Hiperplasia Suprarrenal Congênita/urina , Adulto , Cromatografia Gasosa , Desidroepiandrosterona/urina , Humanos , Masculino , Métodos , Pregnenos/urinaRESUMO
The treatment of a slowly growing invasive prolactinoma with bromocriptine for 8 months resulted in a substantial decrease in plasma prolactin levels despite rapid suprasellar tumor expansion. On exploration, this uncommon observation could be attributed to hematogenous metastasis from an occult gastric adenocarcinoma to the pituitary tumor. Apart from infiltration of neighboring parts of the hypothalamus, autopsy revealed no other hematogenous metastases. This extraordinary type of neoplasm-to-neoplasm metastasis was not shown by computed tomography. This possibility should be considered whenever progressive growth of a pituitary mass is accompanied by a decrease in hormonal overproduction.
Assuntos
Adenocarcinoma Mucinoso/secundário , Adenoma/patologia , Bromocriptina/uso terapêutico , Neoplasias Primárias Múltiplas/patologia , Neoplasias Hipofisárias/secundário , Prolactina/metabolismo , Neoplasias Gástricas/patologia , Adenocarcinoma Mucinoso/patologia , Adenoma/tratamento farmacológico , Adenoma/metabolismo , Idoso , Feminino , Humanos , Hipofisectomia , Recidiva Local de Neoplasia/patologia , Hipófise/patologia , Neoplasias Hipofisárias/tratamento farmacológico , Neoplasias Hipofisárias/patologia , Complicações Pós-Operatórias/patologiaRESUMO
The effect of radiotherapy (24- > 50 Gy) on serum prolactin levels was studied in 28 patients with macroprolactinomas. All had been treated with surgery and 21 had also received bromocriptine interim therapy. Serum prolactin levels decreased in a log-linear fashion with time, both in the patients who never received bromocriptine and those who were treated with this drug. The decline rate of serum prolactin, which thus represented the effect of radiotherapy, was independent of intercurrent bromocriptine therapy, radiation dose and variables such as pre-radiation prolactin levels, tumour grade and tumour extension. During the course of follow-up (3-24 years) serum prolactin normalized in eight patients (28.6%). It is proposed to use the decline rates as a dynamic parameter to predict normalization time and time required for continuance of dopaminergic drug therapy.
Assuntos
Neoplasias Hipofisárias/radioterapia , Prolactina/sangue , Prolactinoma/radioterapia , Adulto , Idoso , Terapia Combinada , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Hipófise/metabolismo , Neoplasias Hipofisárias/sangue , Neoplasias Hipofisárias/fisiopatologia , Prolactinoma/sangue , Prolactinoma/fisiopatologiaRESUMO
Report of a 61-year-old man with progressive mental deterioration and flexion contractures of abdominal muscles and legs as initial signs of hypopituitarism. Five years after onset of symptoms, an endocrinologically non-functioning pituitary adenoma was demonstrated. Thyroid replacement therapy had no effect, but administration of hydrocortisone was followed by rapid recovery. The opportunity to treat such cases of curable dementia is easily missed.
Assuntos
Adenoma Cromófobo/complicações , Insuficiência Adrenal/complicações , Contratura/etiologia , Demência/etiologia , Neoplasias Hipofisárias/complicações , Adenoma Cromófobo/diagnóstico , Insuficiência Adrenal/etiologia , Demência/tratamento farmacológico , Humanos , Hidrocortisona/uso terapêutico , Masculino , Pessoa de Meia-Idade , Neoplasias Hipofisárias/diagnósticoRESUMO
This report describes a patient with a recurring, one stemline-aneuploid, adrenocortical carcinoma. The condition showed a number of unusual characteristics over a period of 22 yr. It changed from a biochemically functioning, low-grade malignant tumour into a non-functioning malignancy with pronounced mitotic activity, accompanied by an ovarian carcinosarcoma 1 yr before death. Quality of life was reasonable for many years despite chemotherapy, consisting of a total of almost 10 kg of o,p'-DDD administered over a period of 8 yr, and the subsequent side effects (e.g. low T4; increased bleeding time). A reduced mineralocorticoid activity, induced by o,p'-DDD, was reversed after discontinuation of o,p'-DDD treatment. During o,p'-DDD administration the substitution requirements for both hydrocortisone and fludrocortisone acetate increased, leading to periods of hypoadrenocorticism with prerenal uraemia.
Assuntos
Neoplasias das Glândulas Suprarrenais/terapia , Carcinoma/terapia , Mitotano/uso terapêutico , Recidiva Local de Neoplasia/terapia , Neoplasias das Glândulas Suprarrenais/patologia , Carcinoma/patologia , Carcinoma/secundário , Carcinossarcoma/patologia , Terapia Combinada , Feminino , Humanos , Neoplasias Pulmonares/secundário , Neoplasias Pulmonares/terapia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Segunda Neoplasia Primária , Neoplasias Ovarianas/patologia , Fatores de TempoRESUMO
Three cases of pituitary adenoma with extension into the nasopharynx and nasal cavity are reported. The occurrence of this rare tumor underscores the need to consider a pituitary tumor whenever a patient presents with rhinologic complaints and destruction of the sellar floor. Epistaxis, although exceptional, may be the first manifestation of a pituitary tumor. Immunohistochemical analysis combined with staining for the pituitary hormones proved to be essential for reaching a definite diagnosis. Magnetic resonance imaging seems to be the modality of choice for differentiation between tumorous and nontumorous sinus obstruction.
Assuntos
Adenoma/patologia , Neoplasias Nasofaríngeas/patologia , Neoplasias Hipofisárias/patologia , Adenoma/diagnóstico , Adenoma/diagnóstico por imagem , Adulto , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Neoplasias Nasofaríngeas/diagnóstico , Neoplasias Nasofaríngeas/diagnóstico por imagem , Invasividade Neoplásica , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/diagnóstico por imagem , Tomografia Computadorizada por Raios XAssuntos
Neoplasias do Córtex Suprarrenal/tratamento farmacológico , Doenças do Sistema Nervoso Central/induzido quimicamente , Mitotano/efeitos adversos , Neoplasias do Córtex Suprarrenal/sangue , Adulto , Doenças do Sistema Nervoso Central/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mitotano/sangue , Testes NeuropsicológicosRESUMO
Three adult patients with micropenis are described: two genetic females, reared as boys, with congenital adrenocortical hyperplasia (CAH), and one male with anorchia. The patients had a male gender identity/role. All three had established a satisfying heterosexual relationship. For only one of the patients intravaginal intercourse was possible. In one patient (with CAH), penile reconstructive surgery was attempted but failed. Nevertheless, he developed a satisfactory sexual relationship with a woman friend. This report illustrates that for patients with micropenis, penile reconstructive surgery is not obligatory for the establishment of a satisfying sexual relationship.